Availability of plasma fractions for therapeutic use in Italy

1983 ◽  
Vol 13 (1) ◽  
pp. 1-4
Author(s):  
Pier Mannuccio Mannucci
Keyword(s):  
Therapeutic Use ◽  
Plasma Fractions

Hazards in the Therapeutic Use of Morphine

1950 ◽  
Vol 34 (6) ◽  
pp. 1761-1777 ◽  
Author(s):  
Harold Jeghers ◽  
Irving B. Brick
Keyword(s):  
Therapeutic Use

Adjuvant therapeutic use of supercritical-ethanol extracts of Curcuma species with cancer drugs in rhabdomycosarcoma cell lines

Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
C Ramachandran ◽  
SM Nair ◽  
KW Quirrin ◽  
EA Escalon ◽  
SJ Melnick
Keyword(s):  
Cell Lines ◽  
Therapeutic Use ◽  
Cancer Drugs ◽  
Supercritical Ethanol ◽  
Ethanol Extracts

Therapeutic use of lowmolecular weight heparin for capillaritis alba

Phlebologie ◽  
2008 ◽  
Vol 37 (05) ◽  
pp. 259-265 ◽  
Author(s):  
H. Kutzner ◽  
G. Hesse
Keyword(s):  
Case Studies ◽  
Randomized Study ◽  
Compression Therapy ◽  
Venous Hypertension ◽  
Therapeutic Use ◽  
Prospective Randomized Study ◽  
Anti Inflammatory ◽  
Positive Effect ◽  
Inflammatory Effect

SummaryThe reason of the so called ulcerated capillaritis alba or idiopathic atrophie blanche is vasculopathy caused by severe venous hypertension. Thrombosed and rarificated vessels worsen the oxygenation, increase permanent inflammation and impede the necessary compression therapy. The anti-inflammatory effects of heparin alleviate pain and being independent from the antithrombotic ones it needs much lower doses for treatment. This anti-inflammatory effect is now becoming more important in clinical phlebology. Case studies of more than 50 patients and one prospective randomized study of 87 patients clearly demonstrate the ameliorated healing of ulcerated atrophie blanche. In our office we could document this positive effect with 22 patients. We present the pathophysiology of low molecular heparins for ulcerated capillaritis alba and our own experiences with it.

The Hemostatic Mechanism after Open-Heart Surgery

1978 ◽  
Vol 39 (02) ◽  
pp. 474-487 ◽  
Author(s):  
E R Cole ◽  
F Bachmann ◽  
C A Curry ◽  
D Roby
Keyword(s):  
Extracorporeal Circulation ◽  
Heart Surgery ◽  
Polyacrylamide Gel Electrophoresis ◽  
Open Heart Surgery ◽  
Coagulation System ◽  
Open Heart ◽  
Time Activity ◽  
Post Surgery ◽  
Plasma Fractions ◽  
The Mean

SummaryA prospective study in 13 patients undergoing open-heart surgery with extracorporeal circulation revealed a marked decrease of the mean one-stage prothrombin time activity from 88% to 54% (p <0.005) but lesser decreases of factors I, II, V, VII and X. This apparent discrepancy was due to the appearance of an inhibitor of the extrinsic coagulation system, termed PEC (Protein after Extracorporeal Circulation). The mean plasma PEC level rose from 0.05 U/ml pre-surgery to 0.65 U/ml post-surgery (p <0.0005), and was accompanied by the appearance of additional proteins as evidenced by disc polyacrylamide gel electrophoresis of plasma fractions (p <0.0005). The observed increases of PEC, appearance of abnormal protein bands and concomitant increases of LDH and SGOT suggest that the release of an inhibitor of the coagulation system (similar or identical to PIVKA) may be due to hypoxic liver damage during extracorporeal circulation.

Diagnostic and therapeutic use of endoscopic mucosal resection (EMR)

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
T Szalóki ◽  
V Tóth ◽  
J Liebhardt ◽  
C Molnár ◽  
Z Rádics ◽  
...  
Keyword(s):  
Endoscopic Mucosal Resection ◽  
Therapeutic Use ◽  
Mucosal Resection
Sign in / Sign up

Export Citation Format

Share Document